★
SDGR
Schrodinger Inc · Health Care
FCF-$148mF
Rev+10.6%B
D/E0.30B+
P/S4.5xB
PEG——
59Score
$15.211Y Target$20.53Near-term target
5Y Target$30.59Compound horizon
10Y Target$79.61Long-dated conviction
FCF-$148mTTM · 03/26F
FCF is negative (-$148m) — cash-burning phase; acceptable only for pre-profit spec names · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+10.6%TTM YoYB
Revenue +10.6% — at or above S&P median · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.30totalB+
D/E 0.30 — healthy leverage, well below danger zone · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S4.5xB
P/S 4.5x — in line with software/tech peers
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $1.1b. Down 45% from 52-week high of $27.63 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Free cash flow is negative (-$148m) — capital raises or debt issuance likely required; dilution / leverage risk. Currently unprofitable (margin -40.6%) — path to GAAP profitability is the core thesis risk. Down 45% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $20.53 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $30.59 — requires the platform / technology to reach commercial scale. 10 yr $79.61 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · SDGR
Shares to buy
131
Position size
$1,993
4.0% of portfolio
Stop price
$11.41
25% below $15.21
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.